Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026)

Incannex Healthcare (IXHL) posted quarterly Total Non-Current Liabilities of $2.0 million for Q1 2026, down 73.65% year-on-year from $7.5 million in Q1 2025, and down 73.65% on a QoQ basis from $7.5 million in Q1 2025.

Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Total Non-Current Liabilities for 6 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 73.65% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 73.65% YoY) and the FY2023 annual result came in at $616087.0, changed N/A from the prior year.
  • Total Non-Current Liabilities retreated to $2.0 million in Q1 2026 per IXHL's latest filing, from $7.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for IXHL reached as high as $8.9 million in Q4 2024 and fell as low as $181519.0 in Q4 2022.
  • A 5-year average of $3.8 million and a median of $2.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 1821.01% — and 2026, when it plunged 73.65%.
  • Year by year, Total Non-Current Liabilities stood at $181519.0 in 2022, then jumped by 1821.01% to $3.5 million in 2023, then soared by 153.94% to $8.9 million in 2024, then retreated by 15.62% to $7.5 million in 2025, then tumbled by 73.65% to $2.0 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $2.0 million, $7.5 million, and $8.9 million for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 1.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.97 Mn
Mar 31, 2025 7.47 Mn
Dec 31, 2024 8.86 Mn
Dec 31, 2023 3.49 Mn
Jun 30, 2023 616,087.00
Dec 31, 2022 181,519.00
Jun 30, 2020 955,006.00